MobiHealth News September 10, 2020
Provider buy-in is more important than ever, digital therapeutics stakeholders say.
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS & Health 2.0 Europe Digital Event today, in a session moderated by YourCoach Health chairman and COO Eugene Borukhovich.
“Once a product is CE Marked, has all the clinical evidence, has gone through even an HCA process, that even isn’t enough,” said Jessica Shull, European lead at the Digital Therapeutics Alliance. “So what we’re looking at is countries where there are these frameworks, products have been approved, they’ve been...